Aditya Ansodaria

Aditya earned a Bachelor of Pharmacy (Gujarat Technological University, India) in 2017 and a MS in Biotechnology (Northeastern University) in 2019.  He then went on to positions at Voyager Therapeutics (2019), CRISPR Therapeutics (2020-2021), and Arbor Biotechnologies (2021-2022). His PhD research involves developing non-viral delivery strategies and precision genome engineering tools for efficient and safe in vivo genome engineering. Aditya seeks to improve accessibility of novel RNA and genome engineering therapeutics, especially in underserved demographics and developing economies. Outside the lab, Aditya is a fan of football (Soccer) and enjoys exploring ethnic and local cuisines.